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ABSTRACT Toxoplasma gondii is a major source of congenital disease worldwide,
but the cellular and molecular factors associated with its vertical transmission are
largely unknown. In humans, the placenta forms the key interface between the ma-
ternal and fetal compartments and forms the primary barrier that restricts the hema-
togenous spread of microorganisms. Here, we utilized primary human trophoblast
(PHT) cells isolated from full-term placentas and human midgestation chorionic vil-
lous explants to determine the mechanisms by which human trophoblasts restrict
and respond to T. gondii infection. We show that placental syncytiotrophoblasts,
multinucleated cells that are in direct contact with maternal blood, restrict T. gondii
infection at two distinct stages of the parasite lytic cycle—at the time of attachment
and also during intracellular replication. Utilizing comparative transcriptome se-
quencing (RNA-seq) transcriptional profiling, we also show that human placental tro-
phoblasts from both the second and third trimesters respond uniquely to T. gondii
infection compared to trophoblast cell lines, typified by the upregulation of several
immunity-related genes. One of the most differentially induced genes was the
chemokine CCL22, which relies on the secretion of a parasite effector(s) either dur-
ing or after invasion for its induction. Collectively, our findings provide new insights
into the mechanisms by which the human placenta restricts the vertical transmission
of T. gondii at early and late stages of human pregnancy and demonstrate the exis-
tence of at least two interferon-independent pathways that restrict T. gondii access
to the fetal compartment.
IMPORTANCE Toxoplasma gondii is a major source of congenital disease worldwide
and must breach the placental barrier to be transmitted from maternal blood to the
developing fetus. The events associated with the vertical transmission of T. gondii
are largely unknown. Here, we show that primary human syncytiotrophoblasts, the
fetus-derived cells that comprise the primary placental barrier, restrict T. gondii infec-
tion at two distinct stages of the parasite life cycle and respond to infection by in-
ducing a unique immunomodulatory transcriptional profile. Collectively, our findings
provide important insights into the mechanisms by which human syncytiotropho-
blasts restrict T. gondii infection at early and late stages of human pregnancy, iden-
tify both permissive and resistant human placental cell types, and identify the
placenta-enriched signaling pathways induced in response to infection.
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Toxoplasma gondii is a major source of congenital disease, with ~200,000 globalcases of congenital toxoplasmosis reported each year (1). In the majority of in-
stances (~80%), in utero infections by T. gondii result in a range of severe birth defects,
including ocular disease and developmental delays, and can also result in fetal death
(2). However, despite the clear impact of T. gondii infections on fetal health, the
mechanisms by which the parasite is transmitted from the maternal bloodstream into
the fetal compartment are largely unknown.
In eutherian organisms, the placenta serves as the sole source of gas, nutrient, and
waste exchange between the maternal and fetal compartments and acts as a key
barrier to restrict fetal infections. At the forefront of these defenses is the syncytiotro-
phoblast (SYN), a multinucleated cell layer that comprises the outermost layer of the
human placenta and which is in direct contact with maternal blood. Subjacent to the
SYN layer are cytotrophoblasts (CYTs), mononucleated and proliferative cells that fuse
to replenish the SYN layer throughout pregnancy. Together, these trophoblast layers
form a primary barrier to the passage of pathogens that may infect the fetus by the
hematogenous route.
In general, the pathways that exist in the human placenta to limit the vertical
transmission of microbes are poorly defined. Our previous studies in primary human
trophoblast (PHT) cells have identified at least two potent antiviral pathways that
restrict viral replication in trophoblasts (3, 4). However, these pathways do not appear
to be relevant during infection with nonviral pathogens, including T. gondii (5). While
studies in placental explants suggest that the SYN layer is not permissive to T. gondii
infection (6), the mechanistic basis for SYN resistance is incompletely understood, as is
whether the SYN layer mounts any innate defense in response to parasite exposure.
Moreover, while placental explant models are useful in their recapitulation of placental
structure, they are limited in their capacity to dissect trophoblast cell-type-specific
pathways that might exist to limit T. gondii infection.
In this study, we interrogated the trophoblast cell type specificity of T. gondii
infection utilizing PHT cells isolated from full-term placentas and identified two cellular
mechanisms that mediate SYN-specific resistance to T. gondii infection. In addition to
discovering that SYNs restrict T. gondii attachment and replication while CYTs do not,
we also identified cell signaling pathways uniquely induced by parasite infection in PHT
cells, which included the induction of several immunity-related genes. We show that
the majority of transcriptional changes in PHT cells are specific to the human pathogen
T. gondii and do not occur in response to infection with the closely related parasite
Neospora caninum (which is not known to cause disease in humans). Moreover, we
show that the production of one such uniquely induced immunity-related gene, the T
regulatory (T-reg) chemoattractant CCL22, is dependent on host cell invasion and the
secretion of T. gondii effectors into the host cell. To expand our findings to earlier in
human pregnancy, when the fetus is likely to face the more severe consequences of
congenital T. gondii infections, we also utilized a midgestation chorionic villous explant
model and show that second-trimester SYNs also resist T. gondii attachment and induce
CCL22 in response to infection, whereas the fetus-derived amnion and chorion are
permissive to infection and do not induce CCL22. Taken together, we have identified
previously unknown intrinsic features in primary human placental cells from both the
second and third trimesters of pregnancy that limit T. gondii infectivity at the level of
attachment and replication, and our findings provide details on both host- and
parasite-specific transcriptional responses of placental cells to infection.
RESULTS
Syncytiotrophoblasts isolated from full-term placentas resist T. gondii infec-
tion. We found that PHT cells isolated from full-term placentas exhibited reduced
susceptibility to T. gondii infection compared to primary human foreskin fibroblast
(HFF) cells (see Fig. S1A and B in the supplemental material). These data are consistent
with our previous work demonstrating that PHT cells exhibit reduced susceptibility to
infection by the three major types of T. gondii in North America and Europe compared
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to nonplacental cells (7). Importantly, human trophoblast cell lines (including BeWo,
HTR8, and JEG-3 cells) were unable to recapitulate this restrictive phenotype and were
permissive to parasite infection (Fig. S1C). In addition, this phenotype was specific to
PHT cultures as primary placental fibroblasts were as permissive to infection as were
HFF cells (Fig. S1D).
PHT cells isolated from full-term placentas spontaneously fuse to form SYNs during
their culture period (~72 h), with some retaining a mononuclear CYT phenotype.
Therefore, to determine whether the lack of PHT cell infection occurred in a cell-type-
specific manner, we infected PHT cells with yellow fluorescent protein (YFP)-tagged
T. gondii (RH strain) and quantified parasite growth specifically in CYTs versus SYNs.
These studies revealed dramatic differences in the susceptibilities of SYNs and CYTs to
T. gondii infection—whereas CYTs were permissive to infection, SYNs were highly
resistant (Fig. 1A, left). Furthermore, we observed that parasites within SYNs replicated
to a lesser degree, as indicated by a highly significant reduction in total cell area
occupied by parasites (Fig. 1A). Since T. gondii replicates within a parasitophorous
vacuole (PV) generated at the time of invasion by each individual parasite, the number
of parasites within a PV can serve as an indicator of parasite growth and replication. In
contrast to the PVs in CYTs, those in SYNs most often contained 1 to 2 parasites (Fig. 1A,
right). Importantly, fusion of BeWo cells with forskolin, which induces syncytin-
mediated fusion (7), was not sufficient to confer resistance to T. gondii infection
(Fig. S1E), supporting the idea that this phenomenon is specific to primary cells and
does not rely on fusion alone.
FIG 1 Placental syncytiotrophoblasts resist T. gondii infection. (A) (Left) Immunofluorescence microscopy
of PHT cells inoculated with T. gondii RH strain (green) for ~24 h. Cytokeratin 19 is shown in red, DAPI
is shown in blue, SYN is outlined in cyan, CYT is outlined in white, and the placental fibroblast (PF) is
outlined in yellow. PF cells are distinguished by the lack of cytokeratin 19 (red). (Right) Percentage of cell
area occupied by T. gondii, compared between CYT and SYN. nCYT  24 and nSYN  9, from one
preparation of PHT cells. Two-tailed t test, P  0.0001, with Welch correction for unequal variances. (B)
Transmission electron microscopy of PHT cells infected with T. gondii (RH) for ~23 h. Mononucleated CYT
at left and SYN, identified by its more than two nuclei, at right. Arrows indicate the parasites in the SYN.
Bars, 2 m.
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Transmission electron microscopy (TEM) revealed that, whereas parasite growth and
PV morphology were normal in mononucleated cells within the preparation (which are
likely CYTs but could also be rare contaminating placental fibroblasts), SYN-internalized
parasites were found within PVs containing host cell cytoplasmic contents indicative of
a loss of vacuole integrity (Fig. 1B). Moreover, the parasites within these PVs contained
more vacuoles of minimal electron density and poorly defined organelles (Fig. 1B). This
phenotype is reminiscent of drug-induced death that we observed previously after
treatment with a benzodioxole-containing compound (8), indicating that SYNs have
potent toxoplasmacidal activity. Taken together, these data implicate SYNs as an
innately resistant cellular barrier to T. gondii infection and suggest that unlike other
cultured cells, these cells potently resist T. gondii infection.
SYN-mediated resistance to T. gondii infection occurs at two stages of the
parasite lytic cycle. Our data suggest that SYNs restrict T. gondii infection at a stage
of intracellular parasite growth. The primary mechanisms for cell-autonomous immu-
nity to T. gondii are driven by the effector cytokine gamma interferon (IFN-). However,
we found that uninfected and T. gondii-infected PHT cells had low levels of IFN-
transcript (Fig. 2A) and that culture supernatants were devoid of secreted IFN- protein
(Fig. 2A and B). Importantly, while guanylate binding protein 1 (GBP1) and GBP2 as well
as other innate immunity-related factors (e.g., NOS1, NOS2, and indoleamine 2,3-
dioxygenase [IDO]) have comparatively higher transcript levels in PHT cells (Fig. 2A),
none of these well-characterized IFN--driven host effector proteins were uniquely
expressed in PHT cells (Fig. 2A). These findings suggest that the innate resistance of
SYNs is not dependent on basal expression of IFN- or its stimulation by infection. To
explore other related mechanisms, we performed immunofluorescence microscopy for
markers of autophagy- and lysosome-mediated degradation pathways given the high
level of basal autophagy that we previously observed in PHT cells (4). We found that
there was no association between SQSTM/p62 or the lysosome-associated component
LAMP2 and internalized parasites at either early or later stages of infection (Fig. 2C;
Fig. S2). These findings are consistent with our TEM-based microscopic studies, in which
we did not observe the association between double-membraned autophagosomes or
lysosomes and internalized parasites (Fig. 1B).
In addition to the intracellular control of parasite replication, it is possible that SYNs
are protected from infection by defects in parasite attachment and/or invasion. To
quantify parasite attachment and invasion, we performed a two-step immunoflu-
orescence-based invasion assay to distinguish extracellular from intracellular parasites
(as in reference 9 and other work). PHT cells were exposed to T. gondii (RH-YFP) for 2 h,
at which point monolayers were washed to remove unbound parasites, cells were fixed,
and attached parasites were identified using an antibody to surface antigen 1 (SAG1)
in the absence of cell permeabilization, followed by detection using a secondary
antibody conjugated to Alexa Fluor 594. Samples were then permeabilized and incu-
bated again with anti-SAG1 antibody, which was detected with a secondary antibody
conjugated to Alexa Fluor 633. Using this approach, extracellular parasites exhibited
fluorescence in all channels (YFP, 594, and 633), whereas intracellular parasites exhib-
ited fluorescence in only two (YFP and 633). Using differential interference contrast
(DIC) imaging and automated image analysis, we quantified the extent of attached and
internalized parasites in CYTs versus SYNs, which were easily distinguishable using DIC
based upon the number, size, and clustering of their nuclei. Using this approach, we
found that there were significantly fewer parasites overall (i.e., uninvaded and invaded)
associated with SYNs than with CYTs (normalized for cell area; P  0.010) (Fig. 2D).
However, the percentages of invasion events (of all total parasite associations) were
nearly identical between SYNs and CYTs, demonstrating that while there is a significant
defect in parasite attachment to and/or association with SYNs, there is no obvious
impediment to invasion (Fig. 2E). While we do not know the stage of attachment at
which T. gondii tachyzoites are arrested when associating with SYNs compared to CYTs,
these data point to a defect in T. gondii attachment as a primary mediator of SYN
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FIG 2 SYN-mediated restriction of T. gondii infection is not the result of autophagy, lysosomal degradation, or inability to invade. (A)
Heat map of innate immune effector gene expression as determined by RNA-seq of uninfected (U) and T. gondii (T.g.)-infected HFF,
JEG-3, and PHT cells. FPKM, fragments per kilobase per million. (B) PHT cytokine secretion as detected by Luminex assay of media from
mock- and T. gondii-infected PHT cells. Data shown are from one of two PHT preparations. (C) Immunofluorescence microscopy of PHT
cells infected with T. gondii (RH) (green) at 8 h postinfection. (Top) Infection with YFP-RH at a multiplicity of infection of 10; p62
staining is shown in red. (Bottom) Infection with RH (anti-GRA2, green) at a multiplicity of infection of 2; lysosome-associated
membrane protein 2 (LAMP2) is shown in red; DAPI is shown in blue. (D and E) Quantification of inside/outside staining of T. gondii
(YFP-RH)-infected PHT cells at 2 h postinfection at a multiplicity of infection of 1 in one PHT cell preparation. Using DIC/DAPI images,
cells were classified as mononucleated (CYT) or multinucleated (SYN). (D) To compare the attachment efficiencies between cell types,
the number of internalized parasites per two-dimensional cell area was calculated for 813 cells (nCYT  729, nSYN  84) and the
resulting distributions were compared using the Kolmogorov-Smirnoff test. The comparison used was CYTinside versus SYNinside (P 
0.010). (E) Comparison of percent invaded parasites of all parasite-associated cells by cell type (nCYT  176, nSYN  34).
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resistance to infection in addition to their ability to potently resist parasite replication
when the parasites do successfully invade.
PHT cells have a unique response to T. gondii infection characterized by the
induction of immunity-related transcription factors and chemokines. Given the
dramatic differences in infectivity and growth of T. gondii in PHT cells, we infected PHT
cells or the choriocarcinoma JEG-3 cell line with T. gondii and compared their tran-
scriptional responses to infection using transcriptome sequencing (RNA-seq). Following
infection for 24 h, we identified 401 transcripts of significantly different abundance (P
0.01; fold change, 4) in infected PHT cells and 106 transcripts of different abundance
in infected JEG-3 cells (Fig. 3A and B). To identify which transcripts were uniquely
induced in PHT cells compared to JEG-3 cells and another primary cell line, we
compared these data to a recently published RNA-seq data set from T. gondii-infected
primary HFF cells (10). While we identified 858 host cell transcripts that were of different
abundances in T. gondii-infected HFFs, there was a significant lack of overlap between
infection-altered transcripts in HFF and PHT cells (Fig. 3B). Cluster analysis of all genes
induced in T. gondii-infected PHT cells revealed multiple categories of genes
specifically induced in these cells and not in either HFFs or JEG-3 cells. While some
genes were induced uniquely in PHT cells and were expressed poorly in other cell
types (Fig. 3A, cluster a), others were of high abundance only after infection in PHT
FIG 3 PHT cells infected with Toxoplasma gondii have a unique transcriptional response to infection. (A) Heat map of all genes with
significantly higher transcript abundance in T. gondii-infected (I) PHT cells than in mock-infected (U) cells (P  0.01; fold change, 4).
(B) Genes with significantly higher abundance (P  0.01; fold difference, 4) in PHT cells, HFFs, and JEG-3 cells. (C) Hierarchically
clustered heat map of 40 genes induced in infected PHT cells. Cluster 1 contains genes that are induced in other cell types, while
cluster 2 consists primarily of transcripts induced by T. gondii infection only in PHT cells (27/30). Transcription factors and chemokines
and their receptors are indicated with asterisks. (D) qPCR validation of three genes specifically induced in T. gondii-infected PHT cells
as identified by RNA-seq. Data shown consist of three technical replicates from an independent PHT cell preparation. (E) Induction of
CCL22 secretion in PHT cells requires live parasites. Parasites were incubated at 23°C or 65°C for 1 h prior to being used to infect PHT
cells. Data shown consist of two technical replicates from one PHT cell preparation. ***, P  0.001 following one-way analysis of
variance and multiple-comparison post hoc tests.
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cells but were constitutively expressed in other cell lines/types (Fig. 3A, cluster b).
Focusing on genes uniquely induced in PHT cells compared to other cell types
(cluster 1, Fig. 3C), multiple immunity-related transcription factors (e.g., IRF4 and
EGR4), chemokines (CCL22, CCL17, CCL20, and CCL1) and the chemokine receptor
CCR7 were all significantly induced by T. gondii infection. We confirmed this
cell-type-specific induction of a subset of the cluster 1 genes via reverse transcrip-
tase quantitative PCR (RT-qPCR) (Fig. 3D). Of note, we found that CCL22, a chemo-
kine known to be expressed constitutively during pregnancy (11, 12) and that has
also been found to increase during miscarriage (11), was induced by 400-fold in
infected PHT cells based on RNA-seq and confirmatory RT-qPCR (Fig. 3C and D).
Subsequent experiments with heat-killed T. gondii failed to induce CCL22 secretion
from PHT cells (Fig. 3E), indicating that production of this chemokine requires live
parasites and suggesting that the CCL22 response requires parasite invasion.
Additional experiments treating PHT cultures with either neutralizing antibody to
CCL22 or recombinant CCL22 showed no difference in the infection status of SYNs
(Fig. S3), providing support for the fact that CCL22 is not responsible for the
reduced parasite attachment to or replication within SYNs compared to CYTs. This
finding is consistent with the role of CCL22 as a chemoattractant rather than an
effector cytokine like IFN-.
Infection of PHT cells with Neospora caninum does not induce the production
of immunomodulatory chemokines. Host transcriptional responses to infection with
T. gondii have been shown in a variety of cell types to be specific for T. gondii and are
not associated with infection by one of its apicomplexan relatives, Neospora caninum
(13–15). Unlike T. gondii, N. caninum is not a human pathogen but causes significant
mortality in cattle and dogs and is associated with congenital disease in these animals
(16, 17). To determine the specificity of the host response to T. gondii infection in PHT
cells, we infected cells with T. gondii (RH-YFP) or N. caninum (NC-1-dsRED [18]) and
compared the cellular responses to infection using RNA-seq. We found that N. caninum
failed to significantly induce any of the chemokine/chemokine receptor genes that
were induced by infection with T. gondii of PHT cells (Fig. 4A; asterisks indicate focus
chemokine genes). The remarkable lack of differential transcript abundance in N. cani-
num-infected PHT cells compared to matched T. gondii-infected PHTs was further
illustrated by MA plot (log ratio versus abundance) (Fig. 4B). In PHT cells, we identified
206 genes that were significantly induced by T. gondii infection (P  0.05; fold
induction, 2) and only 10 genes that were significantly induced after N. caninum
infection (Fig. 4C). Consistent with this, infection with N. caninum had no effect on
CCL22 levels, and coinfections with N. caninum and T. gondii showed that there was
also no synergistic or additive effect (Fig. 4D). Importantly, despite the significant
differences in gene induction, we found that PHT cells were similarly susceptible to
N. caninum infection, with CYTs being readily invaded and supportive of parasite
growth, while SYNs exhibited reduced invasion by and growth restriction of N. caninum
in a fashion very similar to that observed for T. gondii (Fig. 4E).
CCL22 induction in PHT cells requires the T. gondii dense granule protein
MYR1. Given that CCL22 induction in PHT cells required live parasites and was not
induced by N. caninum, we reasoned that this induction likely resulted from a T. gondii-
specific parasite effector that would be secreted after host cell invasion. T. gondii MYR1
is a recently identified dense granule protein that is required for the export/secretion
of multiple dense granule effectors (including GRA24, GRA25, and GRA16 [14, 19, 20])
and was discovered based on its role in mediating T. gondii-specific activation of the
transcription factor c-Myc (13). When we infected PHT cells with T. gondii lacking MYR1
(RH-ΔMYR1) and complemented control parasites (RH-ΔMYR1-MYR1c), we found that
CCL22 production by PHT cells was entirely dependent upon MYR1 (Fig. 4F), which
provides strong evidence that T. gondii CCL22 induction in PHT cells is driven by a
MYR1-dependent secreted effector(s).
Second-trimester human placental villi resist T. gondii infection and induce
CCL22 in response to infection. Because PHT cells are isolated from full-term placen-
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tas, we next determined whether SYNs from earlier in human pregnancy also resist
T. gondii infection and similarly induce immunity-related genes. To do this, we utilized
second-trimester chorionic villous explants, which retain the morphology of human
placental villi, including a layer of cytokeratin 19-positive SYNs covering the villous
surfaces (Fig. 5A). Consistent with our findings in PHT cells, and the work of others
utilizing first-trimester explants (6), we found that second-trimester SYNs were resistant
FIG 4 Infection-modulated gene expression is specific to T. gondii and requires parasite effectors. (A) Heat map of 59 genes induced by at least 1.8-fold in PHT
cells (P  0.01) after infection with T. gondii (T.g.) RH strain (multiplicity of infection of 3). Raw count data were converted to normalized RPKM using DESeq2.
Data are also shown for N. caninum (N.c.)-infected (n  3) and mock-infected (n  2) PHTs, and mean centered data were clustered by sample and gene using
the Euclidean distance (implemented in MeViewer [TM4 microarray suite]; see Materials and Methods). Asterisks denote genes that are very highly induced in
T. gondii-infected PHT cells. (B) MA plots of PHTs comparing gene expression profiles in mock- and parasite-infected cells for all 23,735 queried genes. Genes
of higher abundance in uninfected cells are indicated by positive changes, and those of higher abundance in infected cells are indicated by negative changes.
(C) In T. gondii-infected PHTs, 206 genes were found to be of higher abundance than in mock-infected cells, while only 10 such genes were found in
N. caninum-infected PHTs, consistent with the MA plots in panel B above. (D) Results from ELISA showing induction of CCL22 secretion in PHTs infected with
T. gondii but not N. caninum. Host cells were infected with a multiplicity of infection of 2 (for each parasite species), and supernatants were harvested at the
indicated time points. n  2 to 3 wells for all treatments except for 48-h T. gondii and T. gondii/N. caninum (n  1); single PHT cell preparation. (E) PHTs were
infected with NC-1-dsRED N. caninum (multiplicity of infection of 3) for 24 h and stained with cytokeratin 19 antibodies and DAPI. Similarly to T. gondii,
N. caninum grew efficiently in PFs (yellow outlines) and CYTs (white outlines) and poorly or not at all in SYNs (blue outlines). (F) CCL22 induction in PHT cells
requires MYR1. PHTs were infected with either wild-type (WT) RH-YFP T. gondii, RHΔMYR1, or RHΔMYR1 complemented with a hemagglutinin-tagged copy of
MYR1 (RHΔMYR1c). n  3 for each T. gondii strain. Data shown are from one PHT cell preparation.
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to T. gondii infection, even when infected with very high numbers of parasites (107)
(Fig. 5B, left panel). This resistance appears to be primarily at the level of parasite
attachment, as we detected very few internalized parasites in placental villi and most
parasites detected appeared to be extracellular (Fig. 5B, left panel, white arrows).
Importantly, unlike placental villi, we found that fetal membrane (amnion and chorion)
and maternal decidua supported T. gondii replication (Fig. 5B, middle and right panels,
respectively), highlighting the specific resistance of placental villi. In addition, consis-
tent with the work of others utilizing first-trimester explants (6), we found that CYTs
subjacent to the SYN were permissive to T. gondii only when the SYN layer was
breached (Fig. 5C). These data show that the SYN layer also forms a barrier to T. gondii
vertical transmission in midgestation.
Next, we profiled the transcriptional changes induced by T. gondii infection of
second-trimester chorionic villi using RNA-seq to determine whether they responded to
parasite infection similarly to PHT cells from late gestation. We found that 172 tran-
scripts were differentially expressed in response to T. gondii infection of villous explants,
FIG 5 Chorionic villous explants from the second trimester are resistant to T. gondii infection and induce similar cytokine
profiles in response to T. gondii as do full-term PHT cells. (A) Immunofluorescence microscopy of uninfected second-trimester
placental villous explant with SYN localization indicated. Cytokeratin 19 in green; actin in red; DAPI in blue. (B) Immunoflu-
orescence microscopy of midgestation villi (left panel), fetal membrane (middle panel), or decidua (right panel) inoculated with
107 T. gondii cells (RH strain) for 24 h. T. gondii in green; cytokeratin 19 in red; actin in magenta; DAPI in blue. White arrows
denote single parasites in isolated villi and PVs in fetal membrane and decidua. (C) Immunofluorescence microscopy of
midgestation villi inoculated with 107 T. gondii cells (RH strain) for 24 h. T. gondii in green; cytokeratin 19 in red; actin in
magenta; DAPI in blue. Zoomed image from white box denotes PVs in CYTs located beneath a tear in the SYN (white arrow).
(D and E) RNA-seq analysis of T. gondii-infected villous explants. Venn diagram (D) and heat map (E) showing a subset of genes
that are similarly induced in one of the T. gondii-infected villous explants (explant 5) and PHTs. Genes were selected if they
were at least 2-fold induced compared to mock infection and the value was significant using a DESeq2-determined adjusted
P value of 0.05. Explant data in heat map are from 3 genetically distinct placenta preparations, while PHT data shown are
the same as in Fig. 3. I, infected; U, uninfected (mock); FPKM, fragments per kilobase per million. Asterisks denote genes
similarly induced in both explant 5 and PHT cells. (F) ELISA showing T. gondii (RH strain)-mediated enhancement of CCL22
secretion from villous explants at 24 h postinfection.
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with 22 of these transcripts also being differentially expressed in response to infection
of PHT cells, which included EGR3, EGR4, and CCL22 (Fig. 5D and E). We confirmed that
CCL22 was induced at the protein level by enzyme-linked immunosorbent assay (ELISA)
in supernatants from T. gondii-infected second-trimester villi (Fig. 5F). These data
suggest that CCL22 is specifically induced by the human placenta in response to
T. gondii infection at both early and late stages of pregnancy.
DISCUSSION
T. gondii infections present a worldwide threat to pregnant women, and there is an
urgent need to develop novel treatment regimens to block congenital transmission of
T. gondii and other pathogens that pose risks to the developing fetus. Our data
presented here point to a direct role for SYN-intrinsic pathways in the protection of the
fetus from T. gondii infection, making the SYN a highly unique cell type given that a
diverse array of cells studied to date are susceptible to T. gondii infection and replica-
tion. A particularly remarkable feature of the PHT cell culture model is that there are
both permissive and resistant cells in very close proximity, indicating that cell-
autonomous features determine the fate of T. gondii upon interaction with CYTs and
SYNs. Our studies in both human primary full-term and second-trimester SYNs suggest
that these cells evade T. gondii infection at two critical stages of the parasite lytic
cycle—at the point of parasite association with the host cell and during intracellular
growth. Moreover, by comparing cell-type-specific transcriptional profiles from T. gon-
dii-infected primary trophoblasts and placental tissue with those of other cell types, we
identified unique sets of genes induced by T. gondii infection in the human placenta,
including the induction of CCL22 that requires the presence of parasite-encoded MYR1.
Collectively, our data provide significant advances in our understanding of how the
human placenta controls, responds to, and is manipulated by T. gondii infection.
We found that the first point of SYN-mediated restriction of T. gondii infection
occurred at the level of parasite association and/or attachment, which we observed in
SYNs isolated both from full-term placentas and frommidgestation chorionic villi. These
findings are consistent with the previous work of others suggesting that attachment
might be reduced in first-trimester SYNs (6), although this was not directly tested. Our
attachment and invasion data from PHT cells provide direct evidence that SYNs
naturally restrict parasite attachment but are susceptible to invasion once parasite
attachment occurs, which appears to be a rare event. It remains unclear which point of
the attachment process is altered when T. gondii associates with SYNs, but a likely stage
is during the early phase of gliding motility prior to the second phase of attachment
(which is mediated by the secretion of microneme and rhoptry organelles [21]). One
possibility is that when parasites encounter SYNs, they glide less efficiently than on
CYTs or placental fibroblasts, which ultimately results in significantly reduced “full”
attachment (mediated by microneme and rhoptry secretions). Differences in membrane
biochemistry in SYNs versus CYTs and fibroblasts could underlie these important
differences in early parasite association. Differences in glycosaminoglycan (GAG) con-
tent between CYTs and SYNs could also explain these differences given the known
importance of GAGs in parasite gliding motility and attachment (22). However, once
secondary attachment occurs, invasion seems to proceed normally, indicating that
whatever membrane/surface differences there are between CYTs and SYNs, they do not
impact the phase of invasion that requires organelle discharge.
In midgestation chorionic villi, the poor association/attachment phenotype was
even more profound than that observed in PHT cells, with little to no parasite
association with the villi observed. These findings suggest that in addition to biochem-
ical surface differences between SYNs and CYTs, the morphology of the SYN layer itself
may directly impact parasite association and attachment. This could be influenced by
morphological differences in this model, including the positive membrane curvature
associated with the significant branching of the placental villous trees, which might
impact lipid, protein, and/or carbohydrate composition. In addition, the apical surfaces
of SYNs associated with placental explants may be more differentiated than PHT cells,
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which might impact parasite attachment through the presence of a highly dense brush
border in the explant model. Consistent with this, we previously observed very little
T. gondii association in a bead-based three-dimensional cell line model of human SYNs,
which also induces significant membrane curvature and allows for the formation of a
well-differentiated brush border (7).
For parasites that attach to the SYN layer, our data suggest a second level of
resistance to infection that occurs postinvasion. Importantly, in contrast to other cell
types, our data show that this resistance is not mediated by IFN-, which is not basally
expressed in PHT cells or induced by T. gondii infection. Furthermore, we did not find
any evidence for autophagy- or lysosome-mediated degradation pathways in the
intracellular restriction of parasite replication. To date, all known “cell-autonomous”
mechanisms of parasite killing in human cells rely on previous stimulation with IFN-.
For example, IFN- can induce a variety of downstream effector mechanisms depend-
ing on the cell type, including tryptophan starvation in HFFs (23) and decoration of the
vacuole with guanylate binding proteins (24, 25), ubiquitin, or other markers for
autophagy, including LC3B (25, 26). Ultimately, these pathways would lead to lysosomal
fusion with the parasite-containing vacuole and parasite destruction, which we did not
detect in infected SYNs at any time point tested. However, our data conclusively show
that parasites that invade this specific trophoblast cell type are able to form functional
vacuoles but are ultimately destroyed in a fashion reminiscent of some toxoplasmacidal
drugs (8, 27). Hallmarks of parasite killing are vacuolation of the parasites, breakdown
of the vacuolar tubulovesicular network, and lack of integrity of the parasitophorous
vacuolar membrane and leakage of host cytoplasmic contents into the lumen of the
compromised vacuole. These data place PHT cells, and specifically the subpopulation of
fused SYNs, into a rare class of cells that not only restrict the growth of T. gondii after
invasion in the absence of any external stimuli but actively destroy invaded parasites.
While we did not compare them head to head with SYNs, neutrophils restrict T. gondii
growth after invasion but are possibly less toxoplasmacidal than SYNs, given that
neutrophils have been implicated in the spread of T. gondii throughout the intestine in
a murine model (28). Head-to-head comparisons between SYNs and innate immune cell
types like neutrophils will help to illuminate what potential killing mechanisms might
be shared, or not, between these cell types. Moreover, determining the differences
between SYNs and CYTs would require the development of new methods to separate
them for downstream analyses, including RNA-seq and quantitative proteomics.
In addition to resisting T. gondii infection, our data show that PHT cells robustly
induce the chemokine CCL22 in response to infection by a MYR1-dependent effector
secretion mechanism. We do not know which cell types within the PHT preparation
produce CCL22 after exposure to T. gondii, but given the dependence upon successful
invasion for this response, a good candidate cell type is the CYT rather than the SYN,
although cell-specific analyses are required to address this directly. Importantly, the
major inflammatory responses induced in PHT cells by T. gondii infection are not
induced (or are induced much more poorly) after infection with N. caninum, a near
relative of T. gondii that does not successfully infect humans or rodents, suggesting that
it may be a host and/or parasite adaptation that may impact disease outcome.
The precise role of CCL22 in human pregnancy is unknown, but maternal cells
express CCL22 at low levels throughout pregnancy, with increased levels associated
with miscarriage (11). Moreover, the induction of chemokines, including CCL22 and
CCL17, is associated with preterm birth in humans (29) and in small-animal models (30).
The precise role played by CCL22 during T. gondii vertical transmission remains to be
determined. However, exposure of PHT cells to recombinant CCL22 or CCL22-
neutralizing antibody had no impact on parasite replication (see Fig. S3 in the supple-
mental material), supporting the idea that it has no direct antiparasitic activity. A likely
scenario is that the induction of CCL22, and other immunity-related genes, is aimed at
alerting the maternal immune system to placental infection, where it could play any
number of roles in mediating the dialogue between maternal and fetal tissues, such as
enhancing immune cell-mediated protection at the maternal-fetal interface or in
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terminating the pregnancy should levels reach a specific threshold. Given that CCL22
levels are elevated in maternal serum during healthy, infection-free pregnancies (11,
12), CCL22 and its recruitment of regulatory T cells may also play a role in immune
tolerance throughout gestation, which is modulated in response to infection. This
increased T-reg recruitment may even promote T. gondii infection, as was seen in
Listeria and Salmonella infections in the pregnant mouse model (31).
Our findings provide important insights into the molecular and cellular pathways
utilized by human SYNs at both late and middle stages of gestation to restrict T. gondii
access to the fetal compartment. In addition, by characterizing the immunologic
pathways induced by T. gondii infection of SYNs, our findings have uncovered poten-
tially novel biomarkers of infection severity that might have important roles in shaping
the maternal systemic immune response. These findings provide an example of the
signaling cross talk that exists between the maternal and fetal compartments and the
mechanisms by which this signaling is impacted by parasite-associated effectors. Taken
together, these findings provide important insights into T. gondii-induced congenital
disease that could lead to the design of novel therapeutics aimed at reducing congen-
ital toxoplasmosis.
MATERIALS AND METHODS
Cell culture. All cell and tissue cultures were incubated at 37°C and 5% CO2, and all media were
supplemented with 10% fetal bovine serum (FBS) and 50 g/ml penicillin-streptomycin. JAR and HTR8
cells were grown in RPMI 1640 medium (HyClone), BeWo cells were grown in F-12K medium (Corning),
and JEG-3 cells were grown in Eagle’s minimum essential medium (EMEM; Lonza). To induce fusion of
BeWo cells, cells were treated with 10 M forskolin for 24 h and then washed with phosphate-buffered
saline (PBS) before infection. Primary human trophoblast (PHT) cells were isolated from healthy, full-term
pregnancies and were cultured as described previously (3, 4). PHT cells were cultured for ~48 h prior to
infection to allow for SYN formation. Primary placental fibroblasts were isolated and cultured as
described previously (32).
Midgestation placental explants. Human placental tissue from less than 24 weeks of gestation was
obtained from the University of Pittsburgh Health Sciences Tissue Bank through an honest broker system
after approval from the University of Pittsburgh Institutional Review Board and in accordance with the
University of Pittsburgh anatomical tissue procurement guidelines. Chorionic villi, fetal membrane, and
decidua were dissected and cultured in Dulbecco modified Eagle medium (DMEM)–F-12 medium (1:1)
supplemented with 10% FBS, penicillin-streptomycin, and amphotericin B. For T. gondii infections,
isolated tissue was infected immediately following isolation with 2.5 104 to 1 107 parasites for ~24 h.
For imaging, tissue was fixed in 4% paraformaldehyde, and imaging was performed as detailed below.
Parasites. Type I (RH) and type III (CEP) T. gondii and N. caninum (NC-1) tachyzoites were used for this
study. All parasites were maintained by continual passage in human foreskin fibroblast (HFF) cultures
incubated at 37°C and 5% CO2 in DMEM supplemented with 10% FBS, 50 g/ml penicillin-streptomycin,
and 2 mM glutamine. The YFP-RH was a gift from David Roos, and the RH-MYR1-KO and RH-MYR1-KO/
complemented parasites were gifted by John Boothroyd. For infections, infected monolayers were
scraped and syringe lysed to release the tachyzoites. These parasites were then pelleted at 800  g for
10 min, resuspended in fresh medium, filtered through a 5-m filter, and counted to determine the
appropriate dilution for infection. Mock inoculum was produced by filtering out the tachyzoites with an
0.2-m filter.
Parasite growth curves were generated by luciferase assay (Promega) using luciferase-expressing CEP
parasites. Briefly, at each time point, samples were lysed using the passive lysis buffer (Promega) and
stored at 20°C until at least 8 h past the last time point collection. Samples were then thawed and
incubated with substrate, and fluorescence was measured.
RT-qPCR and RNA-seq. RNA was isolated from cultures using the GenElute mammalian total RNA
miniprep kit (Sigma) and the associated DNase digestion set (Sigma). Both a NanoDrop spectrophotom-
eter and an Agilent bioanalyzer were used to determine sample quality. Sequencing libraries were
prepared from 0.2 to 0.9 g of total RNA with the TruSeq stranded mRNA library preparation kit
(Illumina). The Illumina NextSeq 500 sequencer was used for sequencing. CLC Genomics Workbench 9
(Qiagen) was used to map the RNA-seq FASTQ reads to the human reference genome (hg19). Differential
expression analysis was performed using the DESeq2 package in R (33) using a significance cutoff of an
adjusted P value (Padj) of 0.01, unless specified otherwise. Analysis of mock- and T. gondii-infected HFF
cells was based on data sets previously published and deposited in the Sequence Read Archive (SRA):
SRR2644999, SRR2645000, SRR2645001, SRR2645002, SRR2645003, and SRR2645004. Untreated and
mock-infected chorionic villous explant RNA-seq data sets were previously published and deposited in
the SRA: SRR5676707, SRR5676716, SRR5676717, SRR5676703, and SRR5676704. Hierarchical clustering of
log2-transformed read-per-kilobase-per-million (RPKM) data was performed using MeViewer TM4 soft-
ware. Data were either clustered as is or linearly mean centered using Euclidian distance. Color scales
were adjusted for presentation purposes.
For RT-qPCR analyses, RNA was isolated as described above and cDNA was generated using the
iScript cDNA synthesis kit (Bio-Rad), followed by qPCR using a StepOnePlus real-time PCR system (Thermo
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Fisher). The threshold cycle (ΔCT) method was used to determine gene expression and normalized to the
human actin CT of each sample. Primer sequences were as follows: actin, ACTGGGACGACATGGAGAAAAA
(forward, 5= to 3=) and GCCACACGCAGCTC (reverse, 5= to 3=), and CCL22, GTGGTGTTGCTAACCTTC
(forward, 5= to 3=) and GGCTCAGCTTATTGAGAATC (reverse, 5= to 3=). Predesigned primers were ordered
for CCL17 (Qiagen) and CCR7 (Sigma).
Microscopy. Cell monolayers and placenta explants were fixed in 4% paraformaldehyde and
permeabilized with 0.1% Triton X-100 in 1 PBS. Primary antibodies were incubated for 1 h at room
temperature, followed by washing, and then secondary antibodies were conjugated to Alexa Fluor
(Invitrogen) fluorophores for 30 min at room temperature. Following washing, cells/explants were
mounted with 4=,6-diamidino-2-phenylindole (DAPI)–Vectashield (Vector Laboratories), and imaging was
performed on an Olympus FV1000 laser scanning confocal microscope, a Zeiss LSM 710 microscope, or
an Olympus IX83 inverted microscope. In some cases, images were adjusted for brightness and contrast
using Photoshop or Fiji/ImageJ. ImageJ was used for image analyses. Transmission electron microscopy
was performed as described previously (4).
Reagents and antibodies used for immunostaining studies include Alexa Fluor 594- or 633-conjugated
phalloidin (Invitrogen), cytokeratin 19 (Abcam), LAMP2 (Santa Cruz), and SAG1 (mouse monoclonal D61S;
Thermo Fisher).
CCL22 ELISA. CCL22 ELISAs were performed with the human CCL22/MDC DuoSet ELISA (R&D
Systems) per the manufacturer’s instructions.
Luminex. Conditioned medium from cells was analyzed by multiplex Luminex assay by the Univer-
sity of Pittsburgh Cancer Institute (UPCI) Cancer Biomarkers Facility Luminex Core Laboratory.
Statistics. All statistics were calculated using GraphPad Prism. Experiments were performed with
independent preparations of PHT cells and second-trimester villous explants. The data are presented as
the mean  standard deviation (SD). The individual statistical analyses and associated P values are
described in the individual figure legends.
Accession number(s). BioSample accession numbers: SAMN08172699, SAMN08172700,
SAMN08172701, SAMN08172702, SAMN08172703, SAMN08172704, SAMN08172705, SAMN08172706,
SAMN08172707, SAMN08172709, SAMN08172710, SAMN08172711, SAMN08172712, SAMN08172713,
SAMN08172714, SAMN08172715, SAMN08177641, SAMN08177642, SAMN08177643, SAMN08177644.
BioProject accession number: PRJNA422277 (SRP126779).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01678-17.
FIG S1, TIF file, 26 MB.
FIG S2, TIF file, 7.7 MB.
FIG S3, TIF file, 3.5 MB.
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